As of 2026-03-29, the Fair Value of Jazz Pharmaceuticals PLC (JAZZ) is -28.93 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 182.69 USD, the upside of Jazz Pharmaceuticals PLC is -115.83%.
With the market price of 182.69 USD and our fair value calculation, Jazz Pharmaceuticals PLC (JAZZ) is not a good investment. Investing in JAZZ stocks now will result in a potential loss of 115.83%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -329.70 | -224.10 | 414.83 | 560.12 | -356.15 | 13.00 |
| YoY growth | -238.18% | 32.03% | 285.11% | 35.02% | -163.58% | -9.92% |
| Market Cap (mil) | 11,246.40 |
| P/E | |
| Forward P/E |
| EPS | -5.79 |
| Avg earnings growth rate | -9.92% |
| TTM earnings | -356.15 |